Volume 67, Issue 5, Supplement , Pages 2-12, May 2009
American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update
To access this article, please choose from the options below
Approved by the Board of Trustees January 2009.
Dr Ruggiero is a paid consultant for Amgen Corporation and Procter and Gamble and has received honorarium from Novartis; Dr Dodson states no financial arrangements or affiliations with a corporate organization or a manufacturer of products discussed in this article; Dr Assael is a paid consultant for Novartis and has received honoraria from Novartis and Merck; Dr Landesberg has received honoraria from Novartis Pharmaceutical Corporation; Dr Marx is a paid consultant for Medtronics and is a shareholder for Harvest Technologies. He receives royalties from Quintessence Publishing. Stryker, Synthes Maxillofacial, Biomet 3i, and Biomet Microfixation provide residency support at the Miami School of Medicine, although Dr Marx receives no personal monies from this funding. Dr Marx is a voluntary unpaid expert witness for Osborn LLC attorneys in litigation against Novartis Pharmaceuticals and Merck Co. Dr Mehrotra served as a consultant and on the Advisory Board and Speaker's Bureau for Novartis Pharmaceuticals.
PII: S0278-2391(09)00115-3
doi:10.1016/j.joms.2009.01.009
© 2009 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Volume 67, Issue 5, Supplement , Pages 2-12, May 2009
